Filed from the Indore bureau, the report tracks developments in Healthcare for the Sectors desk. Meridian Pharma has been named in connection with the story, with early details pointing to a 9% shift relevant to the healthcare landscape.
Analysts tracking the Sectors desk say the timing lines up with broader activity expected through 2027, though full details are still emerging. The Business Express will update this report as more information is confirmed.
“The numbers speak for themselves, and we expect that trend to hold through the year.”
Arjun Kapoor, Chief Strategy Officer at Meridian Pharma
Sources close to the matter say Meridian Pharma’s Indore operations are central to the development, with a figure near ₹239 crore attached to the broader plan under discussion.